Sudarshan Pharma Industries Ltd (543828) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543828 | NSE: | Pharmaceuticals & Drugs | Small Cap

Sudarshan Pharma Ind Share Price

26.60 -0.04 -0.15%
as on 05-Dec'25 12:04

Sudarshan Pharma Industries Ltd (543828) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543828 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Sudarshan Pharma Ind

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Sudarshan Pharma Industries stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
40.38
Market Cap:
641.1 Cr.
52-wk low:
22.3
52-wk high:
53.5

Is Sudarshan Pharma Industries Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Sudarshan Pharma Ind: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sudarshan Pharma Industries Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 16%12.2%16%19.5%12%14.6%18.7%15.3%13.7%14.3%-
Value Creation
Index
0.1-0.10.10.4-0.10.10.30.10.00.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 37.955.488.2139148193357461466503503
Sales YoY Gr.-46.1%59.2%57.8%6.4%30.7%84.7%29.2%0.9%7.9%-
Adj EPS 0.300.10.30.10.30.60.30.50.80.7
YoY Gr.--88.2%125%177.8%-44%92.9%103.7%-45.5%56.7%59.6%-
BVPS (₹) 0.60.91.122.12.43.14.24.65.35.8
Adj Net
Profit
0.10.20.72.31.32.65.37.211.21816
Cash Flow from Ops. 1.8-1.6-0-10.52.7-3.7-28.89.734.9-
Debt/CF from Ops. 1.2-3.6-1286.2-14.340.411.1-8.3-1.2115-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 33.3%27.7%12.1%7.9%
Adj EPS 9.2%39.9%10.9%59.6%
BVPS27.2%20.6%20.2%14.2%
Share Price - - - -35.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
56.19.312.617.26.912.320.31110.614.811.9
Op. Profit
Mgn %
0.91.10.83.13.33.73.13.24.97.76.4
Net Profit
Mgn %
0.20.30.81.70.91.31.51.62.43.63.2
Debt to
Equity
12.91.81.20.81.11.310.311.40.2
Working Cap
Days
0881029611613511312617021352
Cash Conv.
Cycle
028404261654645811308

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Sudarshan Pharma Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 0.7 0.7
TTM Sales (₹ Cr.) 503 505
BVPS (₹.) 5.8 5.8
Reserves (₹ Cr.) 115 116
P/BV 4.62 4.58
PE 40.38 40.18
From the Market
52 Week Low / High (₹) 22.33 / 53.50
All Time Low / High (₹) 5.18 / 53.50
Market Cap (₹ Cr.) 641
Equity (₹ Cr.) 24.1
Face Value (₹) 1
Industry PE 40.7

Management X-Ray of Sudarshan Pharma Ind:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sudarshan Pharma Ind - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sudarshan Pharma Ind

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales385588139148193357461466503
Operating Expenses 385587135143186346447443464
Manufacturing Costs0001123547
Material Costs365383129137178335431425436
Employee Cost 0122212233
Other Costs 112246791217
Operating Profit 01145711152339
Operating Profit Margin (%) 0.9%1.1%0.8%3.1%3.2%3.7%3.1%3.2%4.9%7.7%
Other Income 0021000133
Interest 00123335916
Depreciation 0000011111
Exceptional Items 000000000-3
Profit Before Tax 001324791521
Tax 0001012245
Profit After Tax 001213571116
PAT Margin (%) 0.2%0.3%0.8%1.7%0.9%1.4%1.5%1.5%2.4%3.2%
Adjusted EPS (₹)0.30.00.10.30.10.30.50.30.50.7
Dividend Payout Ratio (%)0%96%0%0%0%0%0%10%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 03919202330101112127
Share Capital 02510101010242424
Reserves 01491013207788103
Minority Interest0000000000
Debt26101421302931103169
Long Term Debt1234785131010
Short Term Debt138101421241893159
Trade Payables6111216154474926088
Others Liabilities 001123581016
Total Liabilities 82031505899138232285400

Fixed Assets

Gross Block0002688222425
Accumulated Depreciation0000112345
Net Fixed Assets 0002666202120
CWIP 0002001026
Investments 0000000121734
Inventories137101724477584137
Trade Receivables714172627607382123160
Cash Equivalents 01041101200
Others Assets 02777710323844
Total Assets 82031505899138232285400

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 2-2-0-113-4-291035
PBT 001324791521
Adjustment 00123446919
Changes in Working Capital 1-2-2-5-4-4-13-42-13-2
Tax Paid -0-0-0-1-0-1-2-2-2-3
Cash Flow From Investing Activity -0-0-0-3-3-1-2-26-9-20
Capex -0-0-0-3-4-1-1-14-2-1
Net Investments -0-0-0-0-0-0-0-12-2-16
Others 0-00-020-01-6-3
Cash Flow From Financing Activity -22-18-0-1466-12-14
Net Proceeds from Shares 03580026400
Net Proceeds from Borrowing -1-0-423168-2-0
Interest Paid -0-0-1-2-3-3-3-5-9-15
Dividend Paid 00000000-10
Others -0-00-0-00-0-1-01
Net Cash Flow 00-13-2-0-111-120

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/A9.2612.5917.216.6112.6220.0910.7710.6813.28
ROCE (%)N/A12.1515.9819.4912.0214.6418.6815.2513.6514.25
Asset Turnover Ratio4.583.933.463.432.732.463.022.491.81.47
PAT to CFO Conversion(x)N/AN/A-0-0.511-0.8-4.140.912.19
Working Capital Days
Receivable Days636764576582686180103
Inventory Days10152122343936486280
Payable Days60584939416164706562

Sudarshan Pharma Industries Ltd Stock News

Sudarshan Pharma Industries Ltd FAQs

The current trading price of Sudarshan Pharma Ind on 05-Dec-2025 12:04 is ₹26.60.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Sudarshan Pharma Ind stood at ₹641.1.
The latest P/E ratio of Sudarshan Pharma Ind as of 04-Dec-2025 is 40.38.
The latest P/B ratio of Sudarshan Pharma Ind as of 04-Dec-2025 is 4.62.
The 52-week high of Sudarshan Pharma Ind is ₹53.50 and the 52-week low is ₹22.33.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sudarshan Pharma Ind is ₹502.5 ( Cr.) .

About Sudarshan Pharma Industries Ltd

Sudarshan Pharma Industries was originally incorporated on July 23, 2008 as a Private Limited Company as “Sudarshan Speciality Chemsolve Private Limited” under the provisions of the Companies Act, 1956 with the Registrar of Companies, Mumbai. Later in the year 2016, the name of the company was changed from “Sudarshan Specialty Chemsolve Private Limited” to “Sudarshan Pharma Industries Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by its shareholders at the EGM held on November 25, 2016 and vide certificate of incorporation dated December 17, 2016 issued by the Registrar of Companies, Mumbai. Subsequently, pursuant to a Special Resolution of its Shareholders passed in the Extra-Ordinary General Meeting held on December 12, 2016 the company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the company was changed to ‘Sudarshan Pharma Industries Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on January 05, 2017 by the Registrar of Companies, Mumbai.

The company is engaged in the business of manufacturing and trading of specialty chemicals & intermediates for pharma, agro chemicals, coating, paints, adhesive and various other industries. It is also into Active Pharmaceuticals Ingredients manufacturing. Some products it outsources and manufactures at its toll manufacturing facility, it is also into specialty chemicals imports & exports as well as supply of same to the actual users. As per the clients need and requirements, it provides customize specialty chemicals to its clients in India and abroad regularly. Its Specialty chemicals & its Intermediates have wide application in sectors like pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries.

It is also involved in contract manufacturing, outsource & supply of generic pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It carries about Ethical marketing of pharmaceutical formulation & products in the Domestic and International market through its own distribution network and Sales force under its own brands. The company & its executives have developed the skill and expertise in innovation in specialty chemical, bulk drugs, API and pharmaceutical formulation to provide the products having wide application in pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries. It offers services of QC and Formulation Development to provide customised solutions to its customers and assists them in sourcing the innovative products as per their needs.

Business area of the company

The company is engaged in the business of manufacturing and trading of Specialty Chemicals, Intermediates & Active Pharmaceuticals Ingredients.

Products and services of the company

  • Pharmaceuticals, finished formulations, key starting materials for API
  • Bulk drugs and intermediates
  • Paints, coatings, corrosive, inhibitors & inks
  • Food, fragrance & perfumes
  • Pesticides and agro chemicals
  • Fiber, PVC and adhesives
  • Cosmetic and detergents

History and milestones

  • 2008: Incorporation of the company in the name and style of “Sudarshan Specialty Chemsolve Private Limited”
  • 2011: Generic formulations for institution supply, NGO’s and wholesale market
  • 2012: Branded Generic formulations in Maharashtra
  • 2013: Established its footprints in Gujarat, West Bengal, Chhattisgarh and Uttar Pradesh
  • 2014: Introduced brands in New Drug Delivery System
  • 2015: Over 5,000 medical practitioners associated with SPIL
  • 2016: Company’s name was changed from “Sudarshan Specialty Chemsolve Private Limited” to “Sudarshan Pharma Industries Private Limited”
  • 2016: 7 own branded products introduced successfully in Vimac
  • 2017: Conversion of the company from Private Limited Company to Public Limited Company and Change of name of Company to Sudarshan Pharma Industries Limited
  • 2018: Brand Brilliance Award from Asian African leadership forum in Pharma
  • 2019: Launch Hart Kit Loading Dose and Hart Kit-4
  • 2021: VD-Section Got 50.00 crore Government order (Started work on CORONA protection)
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×